January 2023 in “Revista Eletrônica Acervo Saúde” This review reports that post-COVID telogen effluvium may be influenced by immune and psychological factors linked to COVID-19 infection, affecting hair loss.
April 2024 in “REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS” In this study, 41% of participants reported experiencing alopecia post-COVID-19, with notable associations found between the condition and female sex, azithromycin use, and symptoms like fatigue and post-infection skin irritation.
June 2022 in “Research, Society and Development” This literature review explores post-COVID-19 telogen effluvium, noting multiple potential causes for hair loss and highlighting the absence of a specific treatment, based on existing dermatology guidelines.
March 2022 in “Brazilian Journal of Health Review” This study suggests that COVID-19 infection can lead to telogen effluvium, typically occurring 3-6 months post-infection, potentially linked to the virus's inflammatory and anticoagulation effects.
February 2024 in “Recima21” This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.
